As of July 01, 2024, Emcure Pharma IPO has ₹275 as Grey Market Premium, with a price band of ₹960 to ₹1008 per share. Offering lots of 14 shares, the subscription window is open from July 03 to July 05, 2024.
Emcure Pharma Limited IPO GMP Today
The Grey Market Premium (GMP) for Emcure Pharma IPO is ₹275 as of July 01, 2024. This assessment coincides with a price range of ₹960 to ₹1008 per share for the IPO.
Emcure Pharma Limited IPO Review
Emcure Pharmaceuticals shows mixed financial performance. Revenue grew from ₹58,553.87 million in March 2022 to ₹66,582.51 million in March 2024. However, profitability declined, with PAT decreasing from ₹7,025.56 million to ₹5,275.75 million. EPS fell from ₹36.62 to ₹27.54, and RoNW dropped from 33.32% to 16.87%.
Emcure Pharma Limited IPO Date
Emcure Pharma Limited IPO will start accepting subscriptions from July 03, 2024, to July 05, 2024
Emcure Pharma Limited IPO Price
Emcure Pharma Limited IPO price range is ₹960 to ₹1008 per share with a face value of ₹10 each.
Emcure Pharma Limited
Emcure Pharmaceuticals, a leading Indian pharma company, ranks 13th domestically and 4th globally. They excel in gynecology and HIV antivirals, operating in 70+ countries. With 13 advanced manufacturing facilities in India, Emcure produces diverse pharmaceutical products, ensuring cost-effective production and quality control through vertical integration.
How To Apply For Emcure Pharma Limited IPO?
To apply for the Emcure Pharma Limited IPO through Alice Blue, follow these steps:
1. Open a Demat and Trading Account with Alice Blue if you don’t have one.
2. Access IPO details for Nephro Care India Limited on the Alice Blue platform.
3. Place your bid for the desired number of shares within the IPO’s price range.
4. Confirm your information and submit your application quickly.
You can apply for the Emcure Pharma Limited IPO at Alice Blue in just a few clicks!